GALECTIN THERAPEUTICS INC — Director's Dealing 2014

Jan 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2014-01-27

Reporting Person: Martin Rod D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-27	Common Stock	M	33333	$3.00	Acquired	2309519	Indirect
2014-01-27	Common Stock	M	50000	$3.00	Acquired	2359519	Indirect
2014-01-27	Common Stock	M	54166	$3.00	Acquired	2413685	Indirect
2014-01-27	Common Stock	M	51666	$3.00	Acquired	2465351	Indirect
2014-01-27	Common Stock	M	54167	$3.00	Acquired	2519518	Indirect
2014-01-27	Common Stock	M	54167	$3.00	Acquired	2573685	Indirect
2014-01-27	Common Stock	M	55834	$3.00	Acquired	2629519	Indirect
2014-01-27	Common Stock	M	51667	$3.00	Acquired	2681186	Indirect
2014-01-27	Common Stock	M	95000	$3.00	Acquired	2776186	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	33333	Disposed	2019-06-30	Common Stock (33333)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	50000	Disposed	2019-08-12	Common Stock (50000)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	54166	Disposed	2019-09-30	Common Stock (54166)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	51666	Disposed	2019-11-03	Common Stock (51666)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	54167	Disposed	2019-12-08	Common Stock (54167)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	54167	Disposed	2020-01-29	Common Stock (54167)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	55834	Disposed	2020-03-08	Common Stock (55834)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	51667	Disposed	2020-04-30	Common Stock (51667)	Indirect
2014-01-27	Class A-2 Warrant (Right to Buy)	$3.00	M	95000	Disposed	2020-05-10	Common Stock (95000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	91488	Direct

Footnotes

F1: Amount reflects the Issuer's March 23, 2012 one-for-six reverse stock split. This filing amends all previous filings since the reverse stock split to reflect post-split beneficial holdings.

F2: Reporting person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Martin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: On June 30, 2009, 10X Fund, L.P. purchased (a) 250,000 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 83,333 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to
purchase 83,333 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 333,333 shares of Common Stock for $3.00 per share, for aggregate consideration of $500,000.

F4: On August 12, 2009, 10X Fund, L.P. purchased (a) 150,000 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 50,000 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to
purchase 50,000 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 200,000 shares of Common Stock for $3.00 per share, for aggregate consideration of $300,000.

F5: On September 30, 2009, 10X Fund, L.P. purchased (a) 162,500 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 54,166 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant
to purchase 54,166 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 216,666 shares of Common Stock for $3.00 per share, for aggregate consideration of $325,000.

F6: On November 3, 2009, 10X Fund, L.P. purchased (a) 155,000 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 51,666 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant
to purchase 51,666 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 206,667 shares of Common Stock for $3.00 per share, for aggregate consideration of $310,000.

F7: On December 8, 2009, 10X Fund, L.P. purchased (a) 162,500 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 54,167 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant
to purchase 54,167 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 216,667 shares of Common Stock for $3.00 per share, for aggregate consideration of $325,000.

F8: On January 29, 2010, 10X Fund, L.P. purchased (a) 162,500 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 54,167 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to
purchase 54,167 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 216,667 shares of Common Stock for $3.00 per share, for aggregate consideration of $325,000.

F9: On March 8, 2010, 10X Fund, L.P. purchased (a) 167,500 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 55,834 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to
purchase 55,834 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 223,333 shares of Common Stock for $3.00 per share, for aggregate consideration of $335,000.

F10: On April 30, 2010, 10X Fund, L.P. purchased (a) 155,000 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 51,667 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to
purchase 51,667 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 206,667 shares of Common Stock for $3.00 per share, for aggregate consideration of $310,000.

F11: On May 10, 2010, 10X Fund, L.P. purchased (a) 285,000 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 95,000 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to
purchase 95,000 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 380,000 shares of Common Stock for $3.00 per share, for aggregate consideration of $570,000.